Trophoblasts regulate the placental hematopoietic niche through PDGF-B signaling.

[1]  M. Merad,et al.  Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche , 2011, The Journal of experimental medicine.

[2]  V. de Waard,et al.  Erythropoietin accelerates smooth muscle cell-rich vascular lesion formation in mice through endothelial cell activation involving enhanced PDGF-BB release. , 2010, Blood.

[3]  Mark Vermeulen,et al.  Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development. , 2009, Cell stem cell.

[4]  F. Kuypers,et al.  A BRIEF COMMUNICATION , 2009, Experimental biology and medicine.

[5]  S. Fisher,et al.  The human placenta is a hematopoietic organ during the embryonic and fetal periods of development. , 2009, Developmental biology.

[6]  Elaine Dzierzak,et al.  Runx1 is required for the endothelial to hematopoietic cell transition but not thereafter , 2009, Nature.

[7]  Michael S. Becker,et al.  Fate tracing reveals the endothelial origin of hematopoietic stem cells. , 2008, Cell stem cell.

[8]  M. Gassmann,et al.  Placental HIFs as markers of cerebral hypoxic distress in fetal mice. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  J. Cross,et al.  Spatial and temporal expression of the 23 murine Prolactin/Placental Lactogen-related genes is not associated with their position in the locus , 2008, BMC Genomics.

[10]  Johanna Andrae,et al.  Role of platelet-derived growth factors in physiology and medicine. , 2008, Genes & development.

[11]  S. Morrison,et al.  Uncertainty in the niches that maintain haematopoietic stem cells , 2008, Nature Reviews Immunology.

[12]  S. Orkin,et al.  The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. , 2008, Cell stem cell.

[13]  J. Cross,et al.  Diverse subtypes and developmental origins of trophoblast giant cells in the mouse placenta. , 2007, Developmental biology.

[14]  M. Ikawa,et al.  Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer , 2007, Nature Biotechnology.

[15]  M. Chen,et al.  The allantois and chorion, when isolated before circulation or chorio-allantoic fusion, have hematopoietic potential , 2006, Development.

[16]  S. Orkin,et al.  The journey of developing hematopoietic stem cells , 2006, Development.

[17]  J. Cross,et al.  Determinants of trophoblast lineage and cell subtype specification in the mouse placenta. , 2005, Developmental biology.

[18]  K. Ottersbach,et al.  The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. , 2005, Developmental cell.

[19]  S. Orkin,et al.  The placenta is a niche for hematopoietic stem cells. , 2004, Developmental cell.

[20]  Andrius Kazlauskas,et al.  PDGF signaling in cells and mice. , 2004, Cytokine & growth factor reviews.

[21]  Minoru Takemoto,et al.  Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities , 2004, Development.

[22]  Harvey F Lodish,et al.  Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. , 2003, Blood.

[23]  M. Alvarez-Silva,et al.  Mouse placenta is a major hematopoietic organ , 2003, Development.

[24]  S. Masuda,et al.  Erythropoietin and erythropoietin-receptor producing cells demonstrated by in situ hybridization in mouse visceral yolk sacs , 2002, Anatomical science international.

[25]  S. Joseph,et al.  Erythropoietin (Epo) and EpoR expression and 2 waves of erythropoiesis. , 2001, Blood.

[26]  W. Alexander,et al.  Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Koniski,et al.  Spatial and temporal emergence of high proliferative potential hematopoietic precursors during murine embryogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Betsholtz,et al.  Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice. , 2001, Blood.

[29]  A. Yoshimura,et al.  CIS3/SOCS-3 Suppresses Erythropoietin (EPO) Signaling by Binding the EPO Receptor and JAK2* , 2000, The Journal of Biological Chemistry.

[30]  M. Karin,et al.  Requirement for p38α in Erythropoietin Expression A Role for Stress Kinases in Erythropoiesis , 2000, Cell.

[31]  R. Klein,et al.  Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. , 2000, Molecular cell.

[32]  H. Pendeville,et al.  SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis , 1999, Cell.

[33]  C. Betsholtz,et al.  PDGFB regulates the development of the labyrinthine layer of the mouse fetal placenta. , 1999, Developmental biology.

[34]  K. Conrad,et al.  Expression of the erythropoietin receptor by trophoblast cellsin the human placenta. , 1999, Biology of reproduction.

[35]  M. Goldberg,et al.  Regulation of the erythropoietin gene , 1993, Blood.

[36]  J. Fandrey,et al.  Erythropoietin mRNA expression in human fetal and neonatal tissue. , 1998, Blood.

[37]  D. Linzer,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Two Novel Members of the Prolactin/Growth Hormone Family Are Expressed in the Mouse Placenta* , 2022 .

[38]  F. Kuypers,et al.  BRIEF COMMUNICATION. , 1997, Psychological Medicine.

[39]  K. Conrad,et al.  Expression of erythropoietin by the human placenta , 1996 .

[40]  G. Breier,et al.  Coordinate expression of vascular endothelial growth factor receptor‐1 (fit‐1) and its ligand suggests a paracrine regulation of murine vascular development , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[41]  Rudolf Jaenisch,et al.  Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor , 1995, Cell.

[42]  R. Carlini,et al.  Recombinant human erythropoietin stimulates angiogenesis in vitro. , 1995, Kidney international.

[43]  Philippe Soriano,et al.  Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. , 1994, Genes & development.

[44]  B Swolin,et al.  Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. , 1994, Genes & development.

[45]  B. Ebert,et al.  Regulation of the erythropoietin gene. , 1999, Blood.

[46]  C. Heldin,et al.  The Expression of PDGF α- and β-Receptors in Subpopulations of PDGF-Producing Cells Implicates Autocrine Stimulatory Loops in the Control of Proliferation in Cytotrophoblasts that Have Invaded the Maternal Endometrium , 1992 .

[47]  C. Heldin,et al.  The expression of PDGF alpha- and beta-receptors in subpopulations of PDGF-producing cells implicates autocrine stimulatory loops in the control of proliferation in cytotrophoblasts that have invaded the maternal endometrium. , 1992, Growth factors.

[48]  R. Ohlsson,et al.  Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression. , 1991, Development.

[49]  A. Anagnostou,et al.  Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[50]  K. Sawada,et al.  Receptors for erythropoietin in mouse and human erythroid cells and placenta. , 1989, Blood.

[51]  M. Koury,et al.  Erythropoietin messenger RNA levels in developing mice and transfer of 125I-erythropoietin by the placenta. , 1988, The Journal of clinical investigation.

[52]  C. Rodeck,et al.  Studies of circulating hemopoietic progenitor cells in human fetal blood. , 1982, Blood.